Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Dave L Dixon"'
Autor:
Danh Q. Nguyen, Neil Keshvani, Alvin Chandra, Pamela L. Alebna, Dave L. Dixon, Michael D. Shapiro, Erin D. Michos, Laurence S. Sperling, Ambarish Pandey, Anurag Mehta
Publikováno v:
American Journal of Preventive Cardiology, Vol 18, Iss , Pp 100673- (2024)
Objective: Current guidelines for secondary prevention of atherosclerotic cardiovascular disease (ASCVD) recommend targeting a low-density lipoprotein cholesterol (LDL-C) of < 70 mg/dL. However, temporal trends and racial/ethnic- and sex-differences
Externí odkaz:
https://doaj.org/article/8ce752f14fcd43978abe2dacd9ccf6ea
Publikováno v:
American Journal of Preventive Cardiology, Vol 17, Iss , Pp 100638- (2024)
Metabolic-dysfunction associated steatotic liver disease (MASLD) affects 1 out of every 3 individuals in the adult population and the disease prevalence is predicted to increase worldwide. Patients with MASLD are also burdened by cardiovascular disea
Externí odkaz:
https://doaj.org/article/754ef48711844676b255eaa7d3012383
Autor:
Benjamin Van Tassell, Virginia Mihalick, Georgia Thomas, Amr Marawan, Azita H. Talasaz, Juan Lu, Le Kang, Amy Ladd, Juan Ignacio Damonte, Dave L. Dixon, Roshanak Markley, Jeremy Turlington, Emily Federmann, Marco Giuseppe Del Buono, Giuseppe Biondi-Zoccai, Justin M. Canada, Ross Arena, Antonio Abbate
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-9 (2022)
Abstract Background Heart failure (HF) is a global leading cause of mortality despite implementation of guideline directed therapy which warrants a need for novel treatment strategies. Proof-of-concept clinical trials of anakinra, a recombinant human
Externí odkaz:
https://doaj.org/article/191bce082ed944379e9c364d80ba6e7e
Autor:
Salim S. Virani, Karen Aspry, Dave L. Dixon, Keith C. Ferdinand, Paul A. Heidenreich, Elizabeth J. Jackson, Terry A. Jacobson, Janice L. McAlister, David R. Neff, Martha Gulati, Christie M. Ballantyne
Publikováno v:
American Journal of Preventive Cardiology, Vol 13, Iss , Pp 100472- (2023)
Despite the established role of low-density lipoprotein cholesterol (LDL-C) as a major risk factor for cardiovascular disease (CVD), and the persistence of CVD as the leading cause of morbidity and mortality in the United States, national quality ass
Externí odkaz:
https://doaj.org/article/2d8f8ebe9f0e427090a22fcf4f5173e3
Autor:
Lana JSargent, Marissa Mackiewicz, Youssef Roman, Ana Diallo, Sally Russell, Katherine Falls, Kristin M. Zimmerman, Dave L. Dixon, Elizabeth Prom‐Wormley, Sarah Hobgood, Sarah K. Lageman, Faika Zanjani, Elvin T. Price
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 2, Pp 437-444 (2021)
Older adults (i.e., 60 years and older), are the leading consumers of medications, and consequently are suffering the most from medication‐related adverse events. Not only are older adults the largest consumers of medications, they are more likely
Externí odkaz:
https://doaj.org/article/796f4ec5140e447d80a103bc84160d6e
Autor:
Michael Kelly, Dave L. Dixon
Publikováno v:
American Heart Journal Plus, Vol 16, Iss , Pp 100138- (2022)
Externí odkaz:
https://doaj.org/article/8976ead481da480fa41b267cbd78f3cf
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 5, Iss , Pp 100124- (2022)
Background: Job satisfaction affects organizational outcomes including performance and retention. The pharmacy job satisfaction literature points to several predictors of job satisfaction, but educational debt and various work settings have not been
Externí odkaz:
https://doaj.org/article/c96280fbaedb475f8ab29b30212d8514
Autor:
Graham T. Gipson, Salvatore Carbone, Jing Wang, Dave L. Dixon, Ion S. Jovin, Daniel E. Carl, Todd W. Gehr, Shobha Ghosh
Publikováno v:
Kidney International Reports, Vol 5, Iss 2, Pp 199-210 (2020)
Introduction: Although chronic kidney disease (CKD) is associated with increased risk for coronary artery disease (CAD), the underlying mechanisms are not completely defined. In the present study, we tested the hypothesis that flux of cholesterol fro
Externí odkaz:
https://doaj.org/article/4f90cb1e673b490c8c2b16177c14574f
Autor:
Salvatore Carbone, Dave L. Dixon
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-13 (2019)
Abstract Canagliflozin is a sodium glucose co-transporter 2 (SGLT2) inhibitor that reduces blood glucose, as well as blood pressure, body weight, and albuminuria in patients with type 2 diabetes mellitus (T2DM). In the CANagliflozin cardioVascular As
Externí odkaz:
https://doaj.org/article/1267508a351941fea57843b977254413
Autor:
Michelle M. Kittleson, Gurusher S. Panjrath, Kaushik Amancherla, Leslie L. Davis, Anita Deswal, Dave L. Dixon, James L. Januzzi, Clyde W. Yancy
Publikováno v:
Journal of the American College of Cardiology. 81:1835-1878
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e214c181ebb5eafcb4258f8d619895b3
https://doi.org/10.1016/j.jacc.2023.03.393
https://doi.org/10.1016/j.jacc.2023.03.393